5941153bb7
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
4.5 KiB
4.5 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) | Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) | us/states/md | Maryland General Assembly | 2022 | HB 1397 | Maryland HB 1397 (2022) |
|
enacted |
|
3 | 14 | 2 | 2022-02-17 | 2022-05-16 | openstates | ocd-bill/51ee8ac3-c05f-4647-bff5-425b339347a8 | http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb1397?ys=2022RS&search=True | 5aff2044a224fb8c761518816584dd75c42d73d430ee53cff94b2e2081afb82f | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Maryland HB 1397 (2022) — Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Chapter - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) (committee substitute) — source
- First - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) (committee substitute) — source
- Third - Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act) (committee substitute) — source
Votes
- On Third Reading — 130–0 (pass) · lower
- On Third Reading — 45–0 (pass) · upper
Sponsors
- B. Barnes — primary (person)
- Bagnall — primary (person)
- Bhandari — primary (person)
- Carey — primary (person)
- Carr — primary (person)
- Charles — primary (person)
- Chisholm — primary (person)
- Cullison — primary (person)
- Henson — primary (person)
- Hill — primary (person)
- Howell — primary (person)
- Johnson — primary (person)
- K. Young — primary (person)
- Kaiser — primary (person)
- Kelly — primary (person)
- Kerr — primary (person)
- Kipke — primary (person)
- Landis — primary (person)
- Lehman — primary (person)
- Morgan — primary (person)
- Pena-Melnyk — primary (person)
- Pendergrass — primary (person)
- R. Lewis — primary (person)
- Reilly — primary (person)
- Reznik — primary (person)
- Rosenberg — primary (person)
- Saab — primary (person)
- Sample-Hughes — primary (person)
- Szeliga — primary (person)
- Valderrama — primary (person)
- Valentino-Smith — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2022-02-17 First Reading House Rules and Executive Nominations
referral-committee - 2022-03-03 Rereferred to Health and Government Operations
- 2022-03-03 Hearing 3/15 at 1:30 p.m.
- 2022-03-18 Favorable with Amendments Report by Health and Government Operations
committee-passage-favorable - 2022-03-18 Favorable with Amendments {
committee-passage-favorable - 2022-03-18 Second Reading Passed with Amendments
- 2022-03-21 Third Reading Passed
passage - 2022-03-21 Referred Finance
referral-committee - 2022-04-04 Favorable Report by Finance
committee-passage-favorable - 2022-04-05 Favorable Adopted
committee-passage-favorable - 2022-04-05 Second Reading Passed
- 2022-04-06 Third Reading Passed
passage - 2022-04-07 Returned Passed
- 2022-05-16 Approved by the Governor - Chapter 405
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/51ee8ac3-c05f-4647-bff5-425b339347a8. Confidence: reported (aggregated from official Maryland legislature records).